Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package

TheMotleyFool

0 0

4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package

Major government spending bills tend to create both winners and losers. The $1.9 trillion stimulus bill recently passed by Congress and signed into law by President Joe Biden is no exception. In this Motley Fool Live video, recorded on March 10, Fool.com contributors Keith Speights and Brian Orelli discuss four pharma stocks that could be losers as a result of the legislation.

Source Fool.com

Like: 0

ABBV

Share